The greater effectiveness of the immunity developed by living vaccines compared to that afforded by killed bacteria has been clearly established for several infections caused by facultative intracellular parasites (5, 11, 13) . Earlier studies have shown that this is also true for Salmonella enteritidis infections in mice immunized with living and dead S. gallinarum vaccines (2) .
In the past, claims have been made that antigenically unrelated organisms can produce crossprotection against different infections (4, 6) . Jenkin and,Rowley (7) reported the isolation of a "protective" antigen from S. typhimurium; they asserted that a number of other unrelated bacterial species, which could protect mice against virulent challenge by S. typhimurium, also contained this antigen. However, attempts to detect the presence of a similar type of protective antigen in S. enteritidis were unsuccessful (3) .
In a series of earlier studies, immunity to Salmonella infections was shown to be cellular in nature, with antibody playing a relatively minor role (1, 2, 10) . The degree of immunity to S. enteritidis challenge in mice vaccinated with living suspensions of the antigenically unrelated S. montevideo varied with the size of the residual vaccinating population (2) . At the same time, an antigenically related organism, S. pullorum, was unable to establish a stable liver and spleen population in mice and to generate an effective antibacterial immunity against S. enteritidis.
The present study was designed to measure, with some precision, the degree of cross-protection against S. enteritidis after immunization with living vaccines of a number of unrelated gramnegative bacilli. Media and cultural conditions were similar to those described in a previous paper (2) , except that the S. marcescens cultures were always incubated at 30 C for 4 days to allow maximal pigmentation of the colonies.
Living vaccines were prepared and administered as described previously (2) . The viability of all living vaccines and challenge bacterial suspensions was checked immediately after the injections had been completed by plating suitable 10-fold dilutions of each preparation on Blood Agar Base plates (Difco). P. aeruginosa, P. vulgaris, and S. marcescens could be readily distinguished from S. enteritidis on cultural grounds. Vaccinated and normal control mice were challenged with 1,000 LD5o of a streptomycin-resistant strain of S. enteritidis 5694 (LD5o equals 500 organisms by the intravenous route) 10 days after vaccination, except where indicated otherwise in the text. Mice were always challenged intravenously.
Mice. White Swiss female mice (20 to 25 g) were used throughout this study.
Bacterial enumeration in spleen, liver, and blood. For daily counts, five randomly selected mice from vaccinated and normal groups were used. Combined liver and spleen homogenates were counted by the double-plating technique described previously (10) . Results are expressed as the average of the five mice. The standard deviation was similar to that reported in earlier growth studies (2) . Groups of mice were always set aside to establish the progressive mortality rate in vaccinated and normal animals.
Antisera were prepared by injecting mice intravenously with three doses of 3 X 108 ethyl alcoholkilled organisms at weekly intervals. The mice were bled by heart puncture 1 week after the final injection, and the serum was pooled. The serum was sterilized by Seitz filtration and stored at -20 C. Bacteria (107) were mixed with a 1:5 dilution of serum, and they remained at 4 C for 30 min. The suspension was exposed to sonic vibration (Bronwill Biosonic II oscillator) for 5 sec to break up any clumps of agglutinated bacteria. After suitable dilution in sterile saline, the viability of the opsonized bacteria was determined before injection into mice by the intravenous, intraperitoneal, or subcutaneous routes. The LD80 was established by the method of Reed and Muench (12) . RESULTS S. enteritidis-vaccinated mice. Intravenous injection of 9.0 x 104 S. enteritidis Se 795 cells into 400 mice produced the growth pattern shown in Fig. 1 . Challenge of the 164 surviving mice with 1,000 LDso of streptomycin-resistant S. enteritidis cells at 14 days, 30 days, and 90 days showed that the vaccine conferred complete protection on the mice ( Table 1 ). The liver and spleen counts illustrated that the challenge organisms were not eliminated immediately or completely from the 30-and 90-day mice (Fig. 1) ; however, the overwhelming increase in numbers observed in normal controls was entirely averted. On the average, after 30 days, the vaccinated mice contained fewer than 1,000 viable bacteria in their livers and spleens; two of the five mice tested at this time contained fewer than 100 organisms (the lowest number detectable by the counting methods used in these tests). By 90 dtys, no residual vaccine organisms could be demonstrated in the livers and spleens of sacrificed mice.
This immunity was apparently caused by cellular factors because of the inability of immune sera to protect mice significantly against challenge by S. enteritidis (Table 2) . When bacteria were opsonized with serum obtained from animals vaccinated with either living or killed S. enteritidis, the LD5o after intravenous or intraperitoneal challenge was not significantly altered. Injection of immune serum into intravenously challenged mice with opsonized S. typhimurium had no effect on the growth of the virulent organisms in the livers and spleens of the recipient mice (10) . Similarly, injection of 0.5 ml of serum obtained from mice immunized with living S. enteritidis failed to affect the in vivo growth of an intravenous challenge of virulent S. enteritidis (Collins, unpublished data). Blanden et al. (1) showed that immune serum had protective value against S. typhimurium infections only when the intraperitoneal route of challenge was employed, presumably because the opsonic antibody increased phagocytosis so that the organisms were removed from the extracellular environment before extensive multiplication in the peritoneal cavity could occur. S. enteritidis seemed almost as virulent when given intravenously as when injected intraperitoneally; thus, the inability of serum to protect against intraperitoneal challenge is hardly surprising.
S. typhimurium-vaccinated mice. Intravenous injection of 1,000 S. typhimurium CS cells (approximately 0.5 LD5o) into 200 mice produced the growth pattern shown in Fig. 2 . The 110 survivors were challenged with 1,000 LD50 of streptomycin-resistant S. enteritidis cells 30 days later. Protection against the virulent challenge was very high (Table 1) . The liver and spleen populations of the challenge organisms (Fig. 2) that, although S. enteritidis was almost completely prevented from multiplying in the tissues, it was only gradually eliminated from the liver and spleen. The avirulent strain of S. typhimurium (M 206) gave virtually no cross-protection in animals challenged after 30 days (Table 1) . S. paratyphi C-vaccinated mice. Vaccination of mice with 9 X 105 S. paratyphi C cells resulted in the establishment of stable liver and spleen populations for a period of at least 7 days (Fig. 3) . However, this strain was nonlethal for mice in doses of as high as 107 organisms injected intravenously. Challenge of the vaccinated mice on day 10 showed increased survival compared with the controls (Table 1) , but the liver and spleen counts demonstrated extensive in vivo growth of the challange organism after an initial 3-day lag (Fig. 3) .
S. seftenberg-vaccinated mice. After injection of (Fig.  4) . Challenge of these mice on day 10 with 1,000 7.0 LD5o of S. enteritidis ceUs showed a 1-to 2-day lag, followed by extensive growth of the challenge 6.0 organism (Fig. 4) . However, a considerable number of the challenged mice survived despite extensive multiplication of the challenge organism (Table 1) .40 S. adelaide-vaccinated mice. The strain used in 4.0 this study showed little ability to multiply in = normal mice (Fig. 5) . On an average, only about ' 3.0 103 organisms survived in livers and spleens after ' 10 days. Challenge of these mice with 1,000 LD50 -2.0 S of S. enteritidis cells revealed that little cross-'a, protection was afforded by this vaccinating organism (Table 1) ; thus, rapid and extensive in vivo ._. 6) and in the degree of protection afforded against virulent challenge (Fig. 6 , Table 1 ). (Fig. 7) .
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6.0 DISCUSSION @ 5O In a previous paper (2) , in which the immunogenicity of living suspensions of three anti-4.0 . genically related Salmonella species were compared, it was shown that S. gallinarum grew well . in vivo and established a persistent population. "protection" ( Table 1) . As discussed previously (2) , such data gave no information on the relative 7.0 effectiveness of the different vaccines in terms of host resistance at the time of challenge. The concurrent enumeration studies carried out in 6.0 this investigation showed that only when thehomologous strain was used as the vaccinating E 50 organism was an effective antibacterial immunity :
developed. Those .' / (10) . The growth curves shown in Fig. 3-6 illustrate that all of the Salmonella species tested were capable of survival in vivo for at least 7 days. However, the subsequent growth of the challenge organism in all of these mice emphasizes that the mere survival of the Salmonella vaccine in vivo is not sufficient to generate and to maintain an effective level of nonspecific antibacterial immunity. Previous studies with S. montevideo vaccinated mice clearly demonstrated that the degree of antibacterial immunity to subsequent challenge with virulent S. enteritidis depended on the size of the vaccinating population still present at the time (2) . Thus, the present growth curve data are entirely compatible with the thesis that the cross-protection produced by the antigenically unrelated Salmonella vaccines is caused by the low degree of cellular immunity produced and does not depend on the presence or absence of a specific "protective" factor, as postulated by Jenkin and Rowley (7).
Although conventional "protective" antibody does not appear to play any significant role in the present cross-protection experiments (Table 2) , some degree of antigenic specificity is apparently involved between S. enteritidis and S. typhimurium. When mice vaccinated with S. enteritidis ( Fig. 1) and S. typhimurium (Fig. 2) were rechallenged 30 days later with S. enteritidis, the S. typhimurium-vaccinated mice did not eliminate the antigenically heterologous challenge as rapidly as did the homologously vaccinated mice. Nonetheless, both groups of mice demonstrated complete protection from the highly lethal challenge in terms of death or survival. It appears inescapable that subtle antigenic differences must exist between the two pathogens and that the cells of the homologously stimulated animal can recognize these differences. Since opsonic antibody alone does not show any significant protective effect, the antigenic specificity which has been demonstrated in this study as an accelerated restoration in the level of antibacterial immunity by the homologous challenge population must be explained in terms of an immunological reaction other than that involving conventional antibodies. The possibility that delayed-type hypersensitivity is responsible for the specificity of the recall of host resistance (9) is currently under investigation.
